adult mesenchymal precursor stem cell therapy (Cephalon/Mesoblast)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadult mesenchymal precursor stem cell therapy (Cephalon/Mesoblast)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCNS modulatorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMesoblast Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMesoblast LtdCephalon Inc
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A